COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

12/12/2017 - 13:00

GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 [...]

MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland

12/12/2017 - 13:00

TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its indirect wholly-owned subsidiary, S8 Management, [...]

Zomedica Announces Achievement of Therapeutic Development Milestones

12/12/2017 - 12:55

ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a [...]

Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

12/12/2017 - 12:30

THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ: RPRX ) (“Repros” or the “Company”) today announced that it has entered into a definitive agreement under which Allergan plc (“ [...]

Pluristem Granted Manufacturer Authorization and Good Manufacturing Practice (GMP) Certification by Israel’s Ministry of Health, Supporting Pivotal-Stage Studies

12/12/2017 - 11:30

Authorization is also under the provision of the Conformity Assessment and Acceptance of Industrial Products (CAA) agreement between Israel and the European Union (EU), which will serve to qualify Pluristem’s facilities [...]

Transactions in relation to share buyback program

12/12/2017 - 11:26

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Genetic Technologies Provides Update on Strategic Review Initiative

12/12/2017 - 11:00

MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGen [...]

PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

12/12/2017 - 09:00

OXFORD, United Kingdom, Dec. 12, 2017 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors [...]

Operational Update

12/12/2017 - 07:55

SYDNEY, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (Immutep or the Company), has provided an update on the Company’s two ongoing clinical trials with eftilagimod alpha (LAG- [...]

NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES

12/12/2017 - 07:01

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES Company intends to continue preclinical development in this indication in 2018 [...]

NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1

12/12/2017 - 07:01

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1 La société poursuivra ce [...]

INNATE PHARMA : UPCOMING INVESTOR CONFERENCES

12/12/2017 - 07:01

upcoming investor conferences Marseille, France, December 12, 2017, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the following investor [...]

INNATE PHARMA : PROCHAINS RENDEZ-VOUS INVESTISSEURS

12/12/2017 - 07:01

PROCHAINS RENDEZ-VOUS INVESTISSEURS Marseille, le 12 décembre 2018 Innate Pharma SA (Euronext Paris: FR0010331421 - IPH) annonce aujourd'hui qu'elle sera présente aux événements suivants au cours du premier trimestre [...]

Final Preclinical Asthma Study Confirms Efficacy

12/12/2017 - 01:24

Clear confirmation of efficacy of Cynata’s proprietary Cymerus™ MSCs in second preclinical asthma study Treatment with Cymerus MSCs in clinically-relevant model caused significantly greater reduction of airway [...]

Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint

12/12/2017 - 00:10

PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cromos™ Pharma , a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating Officer. Ms. [...]

Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia

12/12/2017 - 00:00

CAMBRIDGE, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced results from experiments to demonstrate expanded CRISPR genome editing [...]

GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter’s Option to Purchase Additional ADSs

11/12/2017 - 23:19

LONDON, Dec. 11, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Enzymotec Shareholders Approve Proposed Acquisition by Frutarom

11/12/2017 - 23:15

MIGDAL HA’EMEQ, Israel, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ: ENZY ) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional [...]

Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee

11/12/2017 - 23:07

TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has appointed Ottis Jerome “O.J.” [...]